K230794

Substantially Equivalent

Rebuilder Nerve Guidance Conduit

Applicant: Celestray Biotech Company, LLC.,
Product code: JXI
Advisory panel: Neurology
Date received: 2023-03-22
Decision date: 2024-01-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bethesda, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.